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ABSTRACT 
Liposome was derived from two Greek words “Lipos meaning fat and Soma meaning body”. Liposome were spherical shaped vesicles 
consist of phospholipids and cholesterol. Due to their size hydrophobic and lipophilic character   they are very promising system for drug 
delivery. This novel drug delivery system aims to target the drug directly to the site of action. Liposomes are very biocompatible and stable 
and have unique property to entrap both hydrophilic drug and lipophilic drug (amphiphatic nature) to its compartment and lead to   
controlled release effect. They are of 0.05- 5.0 micrometer in diameter. Liposomes are used for the treatment of various diseases like tumors 
or cancer. This article provides an overview of Liposomal Drug Delivery System and various aspects related to liposome that can be studied. 
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Liposomes were spherical shaped concentric vesicles 
derived from two Greek words lipos means fat and soma 
means body1. Liposome were first made by Bangham et al 
in 1961, it was an accidental discovery in which he 
scattered the phosphatidyl choline molecule in water, 
during this  he found that the molecule was forming a 
closed bilayer structure having an aqueous phase which 
were entrapped by a lipid bilayer2. Liposome very useful 
because act as a carrier for a variety of drugs, having a 
potential therapeutic action or other properties. Liposome 
is colloidal carriers, having a size range of 0.01–5.0μm in 
diameter. Drug encapsulated by liposome achieve 
therapeutic level for long duration as drug must first be 
release from liposome before metabolism and excretion3. 
They are small artificial vesicles of spherical shape that can 
be created from cholesterol and natural non-toxic 
phospholipids. Due to their size and hydrophobic and 
hydrophilic character (besides biocompatibility), 
liposome’s are promising systems for drug delivery4. There 
is a unique ability of liposomes to entrap drugs of  both 
aqueous and the lipid phase and it  makes them attractive 
drug delivery systems for hydrophilic and  hydrophobic 
drugs5. 
Liposomes are the novel drug delivery system that aims to 
deliver the drug directly to the place of action. They have 
potential to accommodate both hydrophilic and lipophilic 
compounds to protect the drug from degradation and 
release the active ingredients in a controlled manner6. It 
has been found that glycerol is the backbone of a molecule 
that’s why phospholipid containing glycerol were found to 
be an essential component of liposomal formulation and it 
represents 505 of lipid weight7. 
 
 
Figure 1: Design of liposome 
The structural components are: 
1) Phospholipids 
Phospholipids are the major structural components of 
liposome. The most common phospholipids used in 
liposomal preparation are Phosphatidylcholine (PC8). 
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Phosphatidyl-choline is an amphiphatic molecule consist 
of- 
 A hydrophilic polar head group, phosphocholine  
 A glycerol bridge 
 A pair of hydrophobic acyl hydrocarbon chains 
The chemical structure of naturally occurring 
Phosphatidylcholine has a glycerol moiety attached to two 
acyl chains which may be saturated or unsaturated. The 
stability of liposome membrane depends on the packing of 
hydrocarbon chains of the lipid molecules9. The nature of 
the fatty acid in lipid molecule, such as number of double 
bonds in the chain, is responsible for bilayer properties 
such as elasticity and phase behavior10. Phospholipids are 
very abundant in nature and which contains choline is used 
for the preparation of liposomes. 
Examples of phospholipids are- 
 Phosphatidyl choline (Lecithin) PC 
 Phosphatidyl ethanolamine(Cephalin)-PE 
 Phosphatidyl serine (PS) 
 Phosphatidyl Glycerol (PG) 
2) Cholestrol 
Cholesterol is another important structural component of 
liposome. It is a commonly used sterol. The addition of 
sterols modulates the function of stability and rigidity. It 
does not by itself form a bilayer structure11. It gets 
incorporated into phospholipids in a very high 
concentration up to 1:1 or 2:1 molar ratio of cholesterol to 
phosphatidyl choline. The presence of cholesterol in the 
lipid bilayer enhances the stability and form highly ordered 
and rigid membrane structure12. 
Cholesterol reduces the permeability of water soluble 
molecules and improves the fluidity and stability of 
biological membrane. The interaction and destabilization 
of liposomes was prevented by cholesterol13. 
ADVANTAGES OF LIPOSOMES 
 Amphiphatic in nature so  entrap both kind of drugs 
either water soluble or insoluble 
 Increased efficacy and therapeutic index of drug14. 
 Non ionic 
 Liposome helps to reduce exposure of sensitive tissues 
to toxic drugs. 
 Provides selective passive targeting to tumor tissues. 
 Prevent oxidation of drugs. 
 Liposomes are biodegradable15. 
 Biocompatible  
 Liposome increases stability of drug16. 
 Site avoidance effect. 
 Improve protein stabilization17. 
 Provide sustained release. 
 Direct interaction of drug with cell. 
 Site avoidance effect. 
DISADVANTAGES OF LIPOSOMES 
 Low solubility.  
 Short half life. 
 Production cost is high18. 
 Leakage and fusion of encapsulated drug may occur. 
 Oxidation of phospholipids may occur19. 
 Less stable. 
MECHANISM OF ACTION OF LIPOSOMES  
Liposome performs their action by four different 
mechanism .They are as follows: 
1. Endoytosis – This take place by phagocytic cells of 
reticuloendothelial system such as neutrophills20. 
2. Adsorption – It occurs to the cell surface by non 
specific electrostatic forces or by interaction with cell 
surface components21. 
3. Fusion- It occurs by the insertion of liposomal bilayer 
into plasma membrane with continuous release of 
liposomal content into the cytoplasm22. 
4. Lipid exchange- In this transfer of liposomal lipids to 
the cellular membrane without association of 
liposomal contents23. 
CLASSIFICATION OF LIPOSOMES  
There are various classification of liposome based on- 
a) Structural features
 
Table 1: Liposomes based on vesicle type24 
Vesicle type Diameter Size No. of  Lipid Layer 
Multi lamellar large vesicles (MLV) More than 0.5 µm 5-25 
Oligo lamellar vesicles (OLV) 0.1-1.0 µm Approx 0.5 
Uni lamellar vesicles (UV) All size ranges 1 
Small Uni lamellar vesicles (SUV) 20-100 nm 1 
Medium sized uni lamellar vesicles (MUV) More than 100nm 1 
Large Uni lamellar vesicles (LUV) More than 100nm 1 
Giant Uni lamellar vesicles (GUV) More than 1.0 µm 1 
Multi Vesicular vesicles (MVV) More than 1.0 µm Multicompartmental structure 
 
b) Based upon Conventional Liposomes25 
 Natural lecithin mixtures   
 Liposome with glycolipids 
 Synthetic identical chain phospholipids 
c) Based on method of preparation of liposomes 26 
 
 
Table 2: Liposomes based on vesicle type 
Vesicle 
Type 
Method of preparation 
REV Prepared  by Reverse phase evaporation method 
MLV By  Reverse phase evaporation method 
VET Prepared by extrusion method 
FUV Vesicles prepared by fusion 
FPV Vesicles prepared by French press 
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d) Based upon Specialty liposomes 
 Lipoprotein coated 
 Carbohydrate coated  
 Bipolar fatty acid 
 Antibody directed 
 METHODS OF PREPARATION OF LIPOSOMES 
There are different methods involved in the preparation of 
liposomes  
 General method of preparation – It involves four 
steps for the preparation of liposmes27. 
 
Drying down lipids from organic solvents 
 
Dispersion of lipids in aqueous media 
 
Purification of resultant liposomes 
 
Analysis of final product 
 
I) Passive Loading Techniques 
A) Mechanical dispersion methods 
Lipid hydration method: This is the most common 
method of preparing MLV. 
In this method lipid solution was dried so that a thin film 
was formed at the bottom of RBF and then film was 
hydrated by adding aqueous buffer and vortexing the 
mixture. The hydration step is done at  a temperature 
above the gel liquid crystalline  transition temperature. 
The compound to be encapsulated are added either to  
aqueous buffer or organic solvent  depending upon their 
solubility28. 
Micro emulsification: This method is used for preparing 
SLV. It can be achieved by microemulsifying lipid 
compositions using high shearing stress generated from 
high pressure homogenizer. 
Dried reconstituted vesicles: In this method liposomes 
are added to an aqueous solution containing drug or mixed 
with lyophilized protein, followed by dehydration of 
mixture. 
Freeze thaw method- In this method SUVs were frozen 
rapidly by slow thawing techniqur. The formation of 
unilamellar occurs due to this reason. 
B)    Solvent Dispersion – 
Ethanol injection: A lipid solution of ethanol was added to 
an aqueous buffer    which immediately forms MLV. 
Ether infusion: A solution of lipids dissolved in 
diethylether and is slowly injected to a solution of the 
material to be encapsulated at temperature 55-60◦ C29. 
C) Detergent: Lipids were solubilized by detergents at 
their critical miscelles concentration. As detergent is 
removed, miscelles become richer in phospholipids 
and finally combine to form LUVs. 
II) Active Loading Techniques 
Proliposomes: In this method lipid and drug were coated 
onto a soluble carrier to form free flowing granular 
material in pro-liposome which forms an isotonic 
liposomal suspension on hydration30. 
Lyophillization: The removal of water from products in a 
frozen state at a reduced pressure is called Lyophillization. 
This method is generally used to dry the products that are 
thermolabile 
MARKETED FORMULATIONS OF LIPOSOMES 
In 1995, Doxil (PEGylated liposome-encapsulate 
doxorubicin) became the first liposome drug delivery 
system approved for human use by the US FDA. There was 
list of marketed formulations of liposomes.
 
Table 3: Market product of liposomes 
S.NO PRODUCT NAME  DRUG COMPANY 
1. Ambisome Amphotericin B    NeXstar pharmaceuticals Inc.CO 
2. Abelcet Amphotericin B    The Liposome company N.J. 
3. Amphocil Amphotericin B    Sequus pharmaceuticals Inc.CA 
4. Doxil Doxorubicin    Sequus pharmaceuticals Inc.CA 
5. DaunoXome Daunorubicin    NeXstar pharmaceuticals Inc.CO 
6. Mikasome Amikacin    NeXstar pharmaceuticals Inc.CO 
7. DC99 Doxorubicin    Liposome CO.,NJ,USA 
8 Epaxel Hepatitis A vaccine    Swiss Serum Institue,Switzerland 
9. ELA max Lidocaine    Biozone Labs,CA,USA 
 
 
EVALUATIONS OF LIPOSOMES  
1) Vesicle shape and lamellarity: The shape of the 
vesicles were studied by using electron microscope. 
2) Particle size and distribution:  The size analysed by 
an analyzer based on laser diffraction theory focused 
with minimum power of 5MW31. 
3) Entrapment Efficiency – It determines amount and 
rate of entrapment of water soluble agents in aqueous 
compartment of liposomes. 
This can be calculated by a given formula  
                         
                        
          
 
4) Trapped Volume – It is an important parameter 
related to liposomes .It is aqueous entrapped volume 
per quantity of lipids. This can vary from 0.5 to 30 
microlitre/micromol32. 
5) In vitro drug release – This can be carried by using 
Franz Diffusion cell which has a diameter of 25 mm .It 
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contains reservoir compartment of 22 ml which was 
filled with  buffer which contains 20%v/v methanol to 
maintain sink condition. 
6) Percentage yield of liposomes- The prepared 
liposomes were prepared and      collected. The 
measured weight was divided by the total amount of 
drug and ingredients which were used for the 
preparation of liposomes33. 
STABILITY OF LIPOSOMES 
Therapeutic efficacy of drug molecule is governed by 
stability of liposomes. There are two types of stability- 
Physical Stability- There are various physical processes 
which effects the shelf life of liposomes  like fusion , 
aggregation and shape and size .The general problem that 
occurs is leakage of drug material. The morphology and 
size distribution are important parameters for accessing 
stability.Physical stability can be maintained by avoiding 
excess unsaturation in the phospholipids. They must be 
stored at 4◦C with no freezing and light exposure34. 
Chemical Stability- Phospholipids are unsaturated fatty 
acids prone to hydrolysis alter the stability of drug product. 
Liposomes can be prevented from oxidative degradation by 
adding antioxidants such as butylated hydoxy anisole35. 
APPLICATIONS OF LIPOSOMES 
 Respiratory Diorders- The liposomes have been found 
to possess beneficial effects in the treatment of several 
respiratory   disorders, reason being their better 
sustained release, improved stability and reduced 
toxicity than ordinary aerosols.  Liquid or dry form can 
be taken for inhalation of liposome and release of drug 
has been reported to occur during nebulization . 
 Ophthlamic Disorders- Dry eyes, keratitis, corneal 
transplant rejection, uveitis, ondopthelmitis and 
proliferative vitro retinopathy are the examples of eye 
disorders against which liposomes have been found to 
possess beneficial effects. The drug verteprofin that is 
found to be effective against eye disorders has been 
recently approved as liposomal formulation35. 
 Tumor therapy- Carrier of small cytotoxic molecule 
and vehicles used for macromolecule such as 
cytokines. 
 Immunological adjuvants in vaccines - Liposomes 
used in immunoadjuvant, immunodiagnosis . 
 Liposomes as protein drug delivery-  They are used 
to enhanced drug solubilization 
 Pulmonary Application – They are useful tools for 
pulmonary delivery of drugs due to their solubilization 
capacity12. 
 Liposomes in Cosmetics- They are used in cosmetics 
because their physiology is similar to the cell 
membrane and they release materials to the cells16. 
 Site specific targeting- The immunoliposomes are 
able to recognize and binds to target cells with greater 
specificity. 
 Gene therapy- Liposomes are used widely in gene 
applications to cure diseases. 
ADVANCEMENTS IN LIPOSOMES 
 Ethosomes- They are efficient at delivering to the skin 
composed of soya phosphatidylcholine and 30% 
ethanol36. 
 Immuno liposomes- They were modified with 
antibodies. 
 Niosomes- They is small unilamellar vesicles made from 
non ionic surfactants7. 
 Stealth liposomes- They are new type of liposomes 
which were prepared to improve stability and 
lengthen their half life in circulation. Coating of 
liposomes should be done by poly ethylene glycol 
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